deep_meditation
Well-Known Member
Thanks! I’m hanging in there. I have so much going on now that I’m a bit more wound up than usual. Life is moving ahead in a good way and I don’t need another setback. Hope your friend is doing well.
|
Sponsored by |
|---|
|
|
-
Need help navigating the forum? Find out how to use our features here.
-
Did you know we have lots of smilies for you to use?
Meds Cannabis and Cancer
- Thread starter momofthegoons
- Start date
Thanks! I’m hanging in there. I have so much going on now that I’m a bit more wound up than usual. Life is moving ahead in a good way and I don’t need another setback. Hope your friend is doing well.
Shredder
Dogs like me
Good luck Tuesday!
With a history of illness it's hard to not think the worst when going in for a check up. I've personally felt that I was symptomatic prior to one so I can sympathize. In my case, everything was fine and as soon as I heard that diagnosis (in most cases) I felt better. I wish the same for you @deep_meditation . Please let us know how it goes.
deep_meditation
Well-Known Member
deep_meditation
Well-Known Member
Thanks, Shredder!
Baron23
Well-Known Member
Absolutely wishing you the best of luck on Tues and at the risk of being a bit presumptuous.....no matter what, keep fighting
deep_meditation
Well-Known Member
Absolutely wishing you the best of luck on Tues and at the risk of being a bit presumptuous.....no matter what, keep fighting
Thanks, Baron. I’m heading over there soon. I’ll have some news today but most in about a week or so.
deep_meditation
Well-Known Member
All done with the scan. Now I wait... hopefully this one won’t get flagged. I try not to read the results before I see the doc but it’s hard not to take a peek.
deep_meditation
Well-Known Member
I’m wondering if I should create some type of general support for all thread instead of posting here. That way we could keep this thread dedicated to cannabis and cancer news items.
It would certainly be more personal.... and stories and experiences like your's wouldn't get lost in the shuffle of news items.
deep_meditation
Well-Known Member
I don’t have much news yet. They need to call in the specialists/experts to review my scan as there are some worrisome findings.
On a side note the oncology nurse suggested CBD lotion/salve for some other aches I’ve been having.
On a side note the oncology nurse suggested CBD lotion/salve for some other aches I’ve been having.
Last edited:
Crap.... I'm hoping for the best news for you....
Love that the medical profession is finally starting to realize the benefits of cannabis.
Do you have a source for some?
Baron23
Well-Known Member
deep_meditation
Well-Known Member
Thanks! I’m fortunate that I have some great specialists on my team. I need to note that on my gratitude journal. When things are rough I read that. A woman at a chronic pain support group suggested I keep one.
The dispensary sells some lotion/salve. As far as I know it’s the real deal and “reasonably” affordable. I’m reluctant to try the kind they sell at headshops and grocery stores like Safeway. I should probably try to make my own though. They sell some high CBD flower and concentrates that have varying %’s of THC.
Israeli Cannabis Outfit Cannbit Launches Cancer Study
Tel-Aviv listed cannabis producer Cannbit Ltd. is launching a study to test a cannabis-based treatment for three aggressive types of cancer, Cannbit announced in a filing to the exchange Thursday. The study will be led by cannabis research pioneer Raphael Mechoulam of the Hebrew University of Jerusalem, who chairs Cannbit’s scientific advisory committee. Hadassah University Hospital-Ein Kerem and Sheba Medical Center will collaborate on the study.
Mechoulam, a professor of medicinal chemistry at the Hebrew University, was the first person to identify the main psychoactive constituent in cannabis, THC. Cannbit has a first look agreement for all his research following his appointment to the company. Cannbit will invest $400,000 in the study, plus another $2 million towards a commercial drug license.
Raphael Mechoulam. Photo: Amit Shabi
In return, Cannbit will receive exclusive commercial license for the drug for the duration of the patent (25 years), and for any other intellectual property generated during the study. The rest of the partners will receive 13% of the future revenues generated from the drug or from any of the research stages, according to one person familiar with the matter who spoke to Calcalist on condition of anonymity.
The study will involve molecules found effective in fighting melanoma, neuroblastoma, and Glioblastoma. The Hebrew University’s technology transfer company Yissum owns the intellectual property for the results of the preliminary study, which will later be transferred to Cannbit for the duration of the patent.
Tel-Aviv listed cannabis producer Cannbit Ltd. is launching a study to test a cannabis-based treatment for three aggressive types of cancer, Cannbit announced in a filing to the exchange Thursday. The study will be led by cannabis research pioneer Raphael Mechoulam of the Hebrew University of Jerusalem, who chairs Cannbit’s scientific advisory committee. Hadassah University Hospital-Ein Kerem and Sheba Medical Center will collaborate on the study.
Mechoulam, a professor of medicinal chemistry at the Hebrew University, was the first person to identify the main psychoactive constituent in cannabis, THC. Cannbit has a first look agreement for all his research following his appointment to the company. Cannbit will invest $400,000 in the study, plus another $2 million towards a commercial drug license.
In return, Cannbit will receive exclusive commercial license for the drug for the duration of the patent (25 years), and for any other intellectual property generated during the study. The rest of the partners will receive 13% of the future revenues generated from the drug or from any of the research stages, according to one person familiar with the matter who spoke to Calcalist on condition of anonymity.
The study will involve molecules found effective in fighting melanoma, neuroblastoma, and Glioblastoma. The Hebrew University’s technology transfer company Yissum owns the intellectual property for the results of the preliminary study, which will later be transferred to Cannbit for the duration of the patent.
Study on cannabis chemical as a treatment for pancreatic cancer may have 'major impact,' Harvard researcher says
Scientists from Harvard University's Dana-Farber Cancer Institute have found evidence that a chemical derived from cannabis may be capable of extending the life expectancy for those with pancreatic cancer. (Photo: Pablo PORCIUNCULA BRUNE / AFP)
Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020.
Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber Cancer Institute have released some much-needed good news. In their study, published in the journal Frontiers of Oncology on July 23, the researchers revealed that a chemical found in cannabis has demonstrated “significant therapy potential” in treatment of pancreatic cancer.
The specific drug, called FBL-03G, is a derivative of a cannabis “flavonoid” — the name for a naturally-occurring compound found in plants, vegetables and fruits which, among other purposes, provides their vibrant color. Flavonoids from cannabis were discovered by a London researcher named Marilyn Barrett in 1986, and were later found to have anti-inflammatory benefits.
But while scientists long suspected that cannabis flavonoids may have therapeutic potential, the fact that they make up just 0.14 percent of the plant meant that researchers would need entire fields of it to be grown in order to extract large enough quantities. That changed recently when scientists found a way to genetically engineer cannabis flavonoids — making it possible to investigate their benefits.
Enter the researchers at Dana-Farber, who decided to take the therapeutic potential of one of these flavonoids, FBL-03G, and test it on one of the deadliest cancers through a lab experiment. The results, according to Wilfred Ngwa, PhD, an assistant professor at Harvard and one of the study’s researcher, were “major.”
“The most significant conclusion is that tumor-targeted delivery of flavonoids, derived from cannabis, enabled both local and metastatic tumor cell kill, significantly increasing survival from pancreatic cancer,” Ngwa tells Yahoo Lifestyle. “This has major significance, given that pancreatic cancer is particularly refractory to current therapies.”
Ngwa says that the study is the first to demonstrate the potential new treatment for pancreatic cancer. But on top of successfully killing those cells, the scientist found FBL-03G capable of attacking other cancer cells — which was startling even to them. “We were quite surprised that the drug could inhibit the growth of cancer cells in other parts of the body, representing metastasis, that were not targeted by the treatment,” says Ngwa. “This suggests that the immune system is involved as well, and we are currently investigating this mechanism.”
The significance of that, says Ngwa, is that, because pancreatic cancer is often diagnosed in later stages, once it has spread, and the flavonoids seem to be capable of killing other cancer cells, it may mean the life expectancy of those with the condition could increase.
“If successfully translated clinically, this will have major impact in treatment of pancreatic cancer,” says Ngwa.
The next step for the Harvard researchers is to complete ongoing pre-clinical studies, which Ngwa hopes will be completed by the end of 2020. That could set the stage for testing the new treatment in humans, opening up a new window of hope for a group long in need of it.
Scientists from Harvard University's Dana-Farber Cancer Institute have found evidence that a chemical derived from cannabis may be capable of extending the life expectancy for those with pancreatic cancer. (Photo: Pablo PORCIUNCULA BRUNE / AFP)
Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020.
Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber Cancer Institute have released some much-needed good news. In their study, published in the journal Frontiers of Oncology on July 23, the researchers revealed that a chemical found in cannabis has demonstrated “significant therapy potential” in treatment of pancreatic cancer.
The specific drug, called FBL-03G, is a derivative of a cannabis “flavonoid” — the name for a naturally-occurring compound found in plants, vegetables and fruits which, among other purposes, provides their vibrant color. Flavonoids from cannabis were discovered by a London researcher named Marilyn Barrett in 1986, and were later found to have anti-inflammatory benefits.
But while scientists long suspected that cannabis flavonoids may have therapeutic potential, the fact that they make up just 0.14 percent of the plant meant that researchers would need entire fields of it to be grown in order to extract large enough quantities. That changed recently when scientists found a way to genetically engineer cannabis flavonoids — making it possible to investigate their benefits.
Enter the researchers at Dana-Farber, who decided to take the therapeutic potential of one of these flavonoids, FBL-03G, and test it on one of the deadliest cancers through a lab experiment. The results, according to Wilfred Ngwa, PhD, an assistant professor at Harvard and one of the study’s researcher, were “major.”
“The most significant conclusion is that tumor-targeted delivery of flavonoids, derived from cannabis, enabled both local and metastatic tumor cell kill, significantly increasing survival from pancreatic cancer,” Ngwa tells Yahoo Lifestyle. “This has major significance, given that pancreatic cancer is particularly refractory to current therapies.”
Ngwa says that the study is the first to demonstrate the potential new treatment for pancreatic cancer. But on top of successfully killing those cells, the scientist found FBL-03G capable of attacking other cancer cells — which was startling even to them. “We were quite surprised that the drug could inhibit the growth of cancer cells in other parts of the body, representing metastasis, that were not targeted by the treatment,” says Ngwa. “This suggests that the immune system is involved as well, and we are currently investigating this mechanism.”
The significance of that, says Ngwa, is that, because pancreatic cancer is often diagnosed in later stages, once it has spread, and the flavonoids seem to be capable of killing other cancer cells, it may mean the life expectancy of those with the condition could increase.
“If successfully translated clinically, this will have major impact in treatment of pancreatic cancer,” says Ngwa.
The next step for the Harvard researchers is to complete ongoing pre-clinical studies, which Ngwa hopes will be completed by the end of 2020. That could set the stage for testing the new treatment in humans, opening up a new window of hope for a group long in need of it.
deep_meditation
Well-Known Member
Going in for follow-up scans in about two months. I need to get a card in my new state of residence. I have to mail my old card back to the previous DOH/MMP office and I haven’t been to the old dispensary since June, I think. Ugh. Everything is complicated now.
Do you really? One would think you would just keep it and be able to use it in the 'old state' you lived in. And just get a new one where you are now... Seems so unnecessary.
Best of luck with your scans.
deep_meditation
Well-Known Member
Yea I called the city and they want me to send it in. My new locale has reciprocity with the previous so I could always go back over there. I'm not vaping of late and have been sticking with tinctures and my MCT oil. I don't think I"ve vaped in over a month now... it's hard for me to remember but it must have been a month at this point.
Thanks for the good thoughts.
Indian Researchers Confirm That Cannabis Kills Certain Cancers
A team of researchers in India conducted a meta-analysis of the existing research on cannabis and cancer, and concluded that the results of these studies are too exciting to ignore.
Over the past two decades, the medical community has discovered that medical marijuana can treat a startlingly wide range of illnesses ranging from epilepsy to anxiety to chronic pain. Some researchers even believe that cannabis can be used to treat cancer, an illness that is responsible for over half a million deaths a year in the US alone.
As promising as this idea sounds, there are actually very few studies that have examined whether cannabinoids can help treat the symptoms of cancer or even stop the growth of the disease. A team of researchers from Amity Institute of Biotechnology in India recently conducted a meta-analysis of the existing research on cannabis and cancer, and concluded that the results of these preliminary studies are too exciting to ignore.
“Cannabis was extensively utilized for its medicinal properties till the 19th century,” the researchers wrote. “A steep decline in its medicinal usage was observed later due to its emergence as an illegal recreational drug.”
The study goes on to note that even though researchers across the world have spent decades trying to find a cure for cancer, “the utilization of THC and [cannabis] derivatives is still unexplored pharmacologically owing to their 'habit-forming' nature.”
The study begins with an exploration of prior research showing how cannabis-based medications can effectively treat symptoms of nausea and loss of appetite commonly experienced by individuals undergoing chemotherapy. These discoveries led to the creation of several synthetically-derived THC medications, like Dronabinol and Nabilone, which are now legal in many countries.
The study also notes that “for centuries, cannabinoids have been used as analgesics and surgical anesthesia in ancient China, amelioration of childbirth pain in Israel, and also were widely recognized as potent analgesics in Asia throughout the middle age.” Recent research has confirmed that these ancient treatments were valid, as cannabis does indeed have analgesic effects in addition to anti-inflammatoryproperties.
A small, but slowly expanding field of research is finding that cannabis may be able to do far more than treat the symptoms of cancer, however. The study explains that cannabinoids seem to “exert potent [anti-growth] activity and activate various apoptotic mechanisms eventually leading to cell death” of cancer cells found in glioma, an aggressive brain cancer. In one prior study, glioma patients who received a proprietary blend of THC and CBD lived for an average of one year longer than patients who received a placebo.
In other studies, synthetic cannabinoids were found to actually promote the death of cancer cells responsible for certain kinds of blood or prostate cancer. The researchers note that few professionals have looked into the effects of cannabis on breast, lung, oral, or liver cancer. The few studies that have still show promise, however. In one study, THC was found to be effective against a treatment-resistant form of oral cancer. In another, synthetic CBD helped inhibit the invasiveness of breast cancer.
The study concludes that preliminary research has confirmed that cannabinoids may well have the potential to treat — even cure — cancer, but the ongoing prohibition of cannabis is hampering scientists' efforts to thoroughly research these possibilities.
“Research evidences on cannabinoids have suggested tumor inhibiting and suppressing properties which warrant reconsidering legality of the substance,” the researchers wrote. “Studies on [cannabinoid] receptors, in case of cancers, have demonstrated the psychoactive constituents of cannabinoids to be potent against tumor growth.”
A team of researchers in India conducted a meta-analysis of the existing research on cannabis and cancer, and concluded that the results of these studies are too exciting to ignore.
Over the past two decades, the medical community has discovered that medical marijuana can treat a startlingly wide range of illnesses ranging from epilepsy to anxiety to chronic pain. Some researchers even believe that cannabis can be used to treat cancer, an illness that is responsible for over half a million deaths a year in the US alone.
As promising as this idea sounds, there are actually very few studies that have examined whether cannabinoids can help treat the symptoms of cancer or even stop the growth of the disease. A team of researchers from Amity Institute of Biotechnology in India recently conducted a meta-analysis of the existing research on cannabis and cancer, and concluded that the results of these preliminary studies are too exciting to ignore.
“Cannabis was extensively utilized for its medicinal properties till the 19th century,” the researchers wrote. “A steep decline in its medicinal usage was observed later due to its emergence as an illegal recreational drug.”
The study goes on to note that even though researchers across the world have spent decades trying to find a cure for cancer, “the utilization of THC and [cannabis] derivatives is still unexplored pharmacologically owing to their 'habit-forming' nature.”
The study begins with an exploration of prior research showing how cannabis-based medications can effectively treat symptoms of nausea and loss of appetite commonly experienced by individuals undergoing chemotherapy. These discoveries led to the creation of several synthetically-derived THC medications, like Dronabinol and Nabilone, which are now legal in many countries.
The study also notes that “for centuries, cannabinoids have been used as analgesics and surgical anesthesia in ancient China, amelioration of childbirth pain in Israel, and also were widely recognized as potent analgesics in Asia throughout the middle age.” Recent research has confirmed that these ancient treatments were valid, as cannabis does indeed have analgesic effects in addition to anti-inflammatoryproperties.
A small, but slowly expanding field of research is finding that cannabis may be able to do far more than treat the symptoms of cancer, however. The study explains that cannabinoids seem to “exert potent [anti-growth] activity and activate various apoptotic mechanisms eventually leading to cell death” of cancer cells found in glioma, an aggressive brain cancer. In one prior study, glioma patients who received a proprietary blend of THC and CBD lived for an average of one year longer than patients who received a placebo.
In other studies, synthetic cannabinoids were found to actually promote the death of cancer cells responsible for certain kinds of blood or prostate cancer. The researchers note that few professionals have looked into the effects of cannabis on breast, lung, oral, or liver cancer. The few studies that have still show promise, however. In one study, THC was found to be effective against a treatment-resistant form of oral cancer. In another, synthetic CBD helped inhibit the invasiveness of breast cancer.
The study concludes that preliminary research has confirmed that cannabinoids may well have the potential to treat — even cure — cancer, but the ongoing prohibition of cannabis is hampering scientists' efforts to thoroughly research these possibilities.
“Research evidences on cannabinoids have suggested tumor inhibiting and suppressing properties which warrant reconsidering legality of the substance,” the researchers wrote. “Studies on [cannabinoid] receptors, in case of cancers, have demonstrated the psychoactive constituents of cannabinoids to be potent against tumor growth.”
|
Sponsored by |
|---|
|
|
|